Literature DB >> 8651715

The use of high-frequency ultrasound as a method of assessing the severity of a plaque of psoriasis.

A K Gupta1, D H Turnbull, K A Harasiewicz, D T Shum, G N Watteel, F S Foster, D N Sauder.   

Abstract

BACKGROUND AND
DESIGN: Ultrasound imaging, while initially developed to visualize internal organs, is now being applied to image the skin. In this preliminary study, we used a high-frequency, 40-MHz ultrasound imaging system to provide high-resolution images in psoriasis and examined the relationship between clinical and ultrasound ratings in plaque-type psoriasis. The ultrasound image of a psoriatic plaque demonstrates a superficial echogenic band (band A), followed by a nonchogenic band (band B), and a deeper echogenic band (band C).
RESULTS: In psoriatic plaques (N = 145), the severity of the psoriasis as assessed according to the degree of scaling, erythema, and thickness (SET score) correlated best with the width of band B (P < .001, r = 0.86) and less well with the width of bands A (P < .001, r = 0.59) and C (P < .001, r = 0.44). For the treated psoriatic plaques (n = 64), for which paired readings were available before and after therapy, changes in the SET scores correlated best with the change in the width of band B (P < .001, r = 0.96) and less well with the change in the width of bands A (P < .001, r = 0.61) and C (P < .001, r = 0.45). Ultrasound analyses and clinical evaluation were performed by independent raters.
CONCLUSIONS: The data suggest that high-frequency ultrasound imaging may prove to be a noninvasive technique that can be used as an adjunct to the clinical evaluation of the lesional severity of psoriatic plaques.

Entities:  

Mesh:

Year:  1996        PMID: 8651715

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

Review 1.  Updated Role of High-frequency Ultrasound in Assessing Dermatological Manifestations in Autoimmune Skin Diseases.

Authors:  Ke Chai; Ruixuan Zhu; Fujian Luo; Yaqian Shi; Minghui Liu; Yangfan Xiao; Rong Xiao
Journal:  Acta Derm Venereol       Date:  2022-08-24       Impact factor: 3.875

2.  Doppler versus Histopathology in the Assessment of Egyptian Patients with Psoriasis Treated with Acitretin.

Authors:  Mohamed H Khater; Mohamed Soliman; Amin Amer; Fatehy Khater; Manal R Abd Elhaleem
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

3.  High-frequency ultrasonography of psoriatic skin: A non-invasive technique in the evaluation of the entire skin of patients with psoriasis: A pilot study.

Authors:  Mihaela Cristina Șomlea; Andreea Nicoleta Boca; Alexandra Dana Pop; Roxana Flavia Ilieș; Stefan Cristian Vesa; Anca Dana Buzoianu; Alexandru Tătaru
Journal:  Exp Ther Med       Date:  2019-10-29       Impact factor: 2.447

4.  Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.

Authors:  D Grand; J W Frew; K Navrazhina; J G Krueger
Journal:  Br J Dermatol       Date:  2020-09-06       Impact factor: 9.302

Review 5.  Current applications of high-frequency ultrasonography in dermatology.

Authors:  Adriana Polańska; Aleksandra Dańczak-Pazdrowska; Magdalena Jałowska; Ryszard Żaba; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

6.  Diagnostic role of ultrasound elastography for nail bed involvement in psoriasis.

Authors:  Kiyasettin Asil; Mahizer Yaldiz
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

7.  A sonographic spectrum of psoriatic arthritis: "the five targets".

Authors:  Marwin Gutierrez; Emilio Filippucci; Rossella De Angelis; Giorgio Filosa; David Kane; Walter Grassi
Journal:  Clin Rheumatol       Date:  2009-10-24       Impact factor: 2.980

8.  A Scoping Review of Non-invasive Imaging Modalities in Dermatological Disease: Potential Novel Biomarkers in Hidradenitis Suppurativa.

Authors:  David Grand; Kristina Navrazhina; John W Frew
Journal:  Front Med (Lausanne)       Date:  2019-11-06

9.  A phase I, randomized, double-blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF-06763809 in participants with mild-to-moderate plaque psoriasis.

Authors:  G Berstein; Y Zhang; Z Berger; E Kieras; G Li; A Samuel; T Yeoh; H Dowty; K Beaumont; W Wigger-Alberti; Y von Mackensen; U Kroencke; R Hamscho; S Garcet; J G Krueger; C Banfield; B Oemar
Journal:  Clin Exp Dermatol       Date:  2020-09-14       Impact factor: 3.470

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.